Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.

Abstract

Development of a safe and effective vaccine against herpes simplex virus type 2 (HSV-2) has the potential to limit the global burden of HSV-2 infection and disease, including genital ulcer disease and neonatal herpes, and is a global sexual and reproductive health priority. Another important potential benefit of an HSV-2 vaccine would be to decrease HIV… (More)
DOI: 10.1016/j.vaccine.2017.09.044

Topics

Cite this paper

@article{Schiffer2017BiologicIB, title={Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.}, author={Joshua T. Schiffer and Sami L. Gottlieb}, journal={Vaccine}, year={2017} }